欢迎来到西安迈博睿(Mabioway)生物科技有限公司 Call: 15339069646 | E-mail: info@mabioway.cn 在线留言 |

服务热线

15339069646
网站导航
当前位置: 首页 > 产品展示 > 抗体产品 > 一抗 > 其他抗体
其他抗体
Anti-LCMV surface glycoprotein mAbs [M28](MABL-3617)
  • Anti-LCMV surface glycoprotein mAbs [M28](MABL-3617)

Anti-LCMV surface glycoprotein mAbs [M28](MABL-3617)

简要描述:

For Research Use Only. Not for diagnostic or therapeutic use.

产品参数:

Cat. No.:MABL-3617

Application:cryoEM, in vitro, in vivo, neutralization, ELISA

Isotype:Engineer antibody

Species Reactivity:Lymphocytic choriomeningitis virus (LCMV)

Clone No.:M28

产品价格:¥0

详细介绍
Cat. No.
MABL-3617
Application
cryoEM, in vitro, in vivo, neutralization, ELISA
Isotype
Engineer antibody
Species Reactivity
Lymphocytic choriomeningitis virus (LCMV)
Clone No.
M28
From
Recombinant Antibody
Specificity
This antibody is specific for the LCMV surface glycoprotein. It binds to a pre‑fusion epitope of the LCMV GP complex.
Alternative Names
LCMV surface GP; lineage I Lassa fever virus; lineage I LASV; LASV; Preglycoprotein polyprotein GP complex; Pre‑GP‑C; Stable signal peptide; SSP; Glycoprotein G1; GP1; Glycoprotein G2; GP2; 18.5C‑M28
UniProt
P07399
Immunogen
The original antibody was generated by introducing two mutations (S32R and R55 insertion) into the sequence of the parent clone 18.5C (an isolate from a human survivor of Lassa fever).
Application Notes
Specific target recognition confirmed by ELISA. Fab variant exhibits potent in‑vitro neutralization (IC₅₀ ≈0.51 μg/mL). In murine chronic LCMV model, shows both prophylactic and therapeutic effects, achieves complete viral clearance and prevents weight loss. Enables high‑resolution cryoEM of apo‑ and Fab‑bound LCMV GP trimer, identifying a quaternary pre‑fusion‑specific epitope (Moon‑Walker et al., 2023; PMID:36990092). Fully neutralizes cell‑free LCMV at 5 μg/mL; used to demonstrate ~50% viral spread occurs via antibody‑resistant direct cell‑to‑cell nanotube transfer (Byford et al., 2024; PMID:39578605). First published in Cell Chem Biol, 2023; paper reports prefusion‑trimer cryo‑EM structure and mouse protection by passive M28 administration.
Antibody First Published
Moon-Walker et al. Structural basis for antibody-mediated neutralization of lymphocytic choriomeningitis virus Cell Chem Biol. 2023 Apr 20;30(4):403-411.e4. doi: 10.1016/j.chembiol.2023.03.005. PMID:36990092
Note on publication
The original publication reveals the cryo‐EM structure of the lymphocytic choriomeningitis virus surface glycoprotein in its prefusion trimeric form—alone and bound to a rationally engineered neutralizing antibody (M28)—and demonstrates that passive administration of M28 can protect mice from LCMV challenge.
Size
100 μg Purified antibody.
Concentration
1 mg/ml.
Purification
Protein A affinity purified
Buffer
PBS with 0.02% Proclin 300.
Storage Recommendation
Store at 4⁰C for up to 3 months. For longer storage, aliquot and store at - 20⁰C.

 


服务咨询

留言框

  • 标题:

  • 留言内容:

  • 您的单位:

  • 您的姓名:

  • 联系电话:

  • 常用邮箱:

  • 详细地址:

推荐产品

联系我们

Copyright © 2012-2029 西安迈博睿(Mabioway)生物科技有限公司 版权所有

地址:陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层

电话:15339069646 邮箱:info@mabioway.cn

陕ICP备2021006339号